LB Pharmaceuticals Inc Common Stock (LBRX)
Healthcare
Biotechnology
42.80 $
+6.9%
vs. previous close
Closing price · As of: 3. Aug 2026
LB Pharmaceuticals Inc Common Stock (LBRX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -23 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|
| -9.6 | -16 | -22 | -5.7 | -8.1 | -5.6 | -3.4 | -18 | -23 | -50 | |
| 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.3 | |
| 0.1 | 0.3 | 0.5 | 2.3 | 0.6 | 0.3 | 0.9 | 2.3 | 2.6 | 6.1 | |
| 6.4 | 9.8 | -10.0 | -2.9 | -2.8 | -1.3 | -0.1 | -9.5 | -6.8 | -18 | |
| 0.0 | 0.0 | 0.4 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | |
| -26 | 6.9 | 29 | – | 5.0 | 0.0 | -45 | 0.0 | 0.0 | -45 | |
| 0.0 | – | – | – | – | – | – | – | – | – | |
| 38 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 304 | -1.2 | 94 | 396 | |
| 2.7 | -8.9 | 6.9 | 7.9 | -3.1 | -5.6 | 256 | -20 | 71 | 301 | |
| -9.6 | -16 | -22 | -5.9 | -8.1 | -5.6 | -3.4 | -18 | -23 | -50 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.